Characterization of Fosfomycin and Nitrofurantoin Resistance Mechanisms in <i>Escherichia coli</i> Isolated in Clinical Urine Samples

Fosfomycin and nitrofurantoin are antibiotics of choice to orally treat non-complicated urinary tract infections (UTIs) of community origin because they remain active against bacteria resistant to other antibiotics. However, epidemiologic surveillance studies have detected a reduced susceptibility t...

Full description

Bibliographic Details
Main Authors: Antonio Sorlozano-Puerto, Isaac Lopez-Machado, Maria Albertuz-Crespo, Luis Javier Martinez-Gonzalez, Jose Gutierrez-Fernandez
Format: Article
Language:English
Published: MDPI AG 2020-08-01
Series:Antibiotics
Subjects:
Online Access:https://www.mdpi.com/2079-6382/9/9/534
_version_ 1797555833409634304
author Antonio Sorlozano-Puerto
Isaac Lopez-Machado
Maria Albertuz-Crespo
Luis Javier Martinez-Gonzalez
Jose Gutierrez-Fernandez
author_facet Antonio Sorlozano-Puerto
Isaac Lopez-Machado
Maria Albertuz-Crespo
Luis Javier Martinez-Gonzalez
Jose Gutierrez-Fernandez
author_sort Antonio Sorlozano-Puerto
collection DOAJ
description Fosfomycin and nitrofurantoin are antibiotics of choice to orally treat non-complicated urinary tract infections (UTIs) of community origin because they remain active against bacteria resistant to other antibiotics. However, epidemiologic surveillance studies have detected a reduced susceptibility to these drugs. The objective of this study was to determine possible mechanisms of resistance to these antibiotics in clinical isolates of fosfomycin- and/or nitrofurantoin-resistant UTI-producing <i>Escherichia coli</i>. We amplified and sequenced <i>murA</i>, <i>glpT</i>, <i>uhpT</i>, <i>uhpA</i>, <i>ptsI</i>, <i>cyaA</i>, <i>nfsA</i>, <i>nfsB</i>, and <i>ribE</i> genes, and screened plasmid-borne fosfomycin-resistance genes <i>fosA3</i>, <i>fosA4</i>, <i>fosA5</i>, <i>fosA6</i>, and <i>fosC2</i> and nitrofurantoin-resistance genes <i>oqxA</i> and <i>oqxB</i> by polymerase chain reaction. Among 29 isolates studied, 22 were resistant to fosfomycin due to deletion of <i>uhpT</i> and/or <i>uhpA</i> genes, and 2 also possessed the <i>fosA3</i> gene. Some modifications detected in sequences of NfsA (His11Tyr, Ser33Arg, Gln67Leu, Cys80Arg, Gly126Arg, Gly154Glu, Arg203Cys), NfsB (Gln44His, Phe84Ser, Arg107Cys, Gly192Ser, Arg207His), and RibE (Pro55His), and the production of truncated NfsA (Gln67 and Gln147) and NfsB (Glu54), were associated with nitrofurantoin resistance in 15/29 isolates; however, the presence of <i>oqxAB</i> plasmid genes was not detected in any isolate. Resistance to fosfomycin was associated with the absence of transporter UhpT expression and/or the presence of antibiotic-modifying enzymes encoded by <i>fosA3</i> plasmid-mediated gene. Resistance to nitrofurantoin was associated with modifications of NfsA, NfsB, and RibE proteins. The emergence and spread of these resistance mechanisms, including transferable resistance, could compromise the future usefulness of fosfomycin and nitrofurantoin against UTIs. Furthermore, knowledge of the genetic mechanisms underlying resistance may lead to rapid DNA-based testing for resistance.
first_indexed 2024-03-10T16:54:17Z
format Article
id doaj.art-c575f59cff094175aa2ae49476acfaf4
institution Directory Open Access Journal
issn 2079-6382
language English
last_indexed 2024-03-10T16:54:17Z
publishDate 2020-08-01
publisher MDPI AG
record_format Article
series Antibiotics
spelling doaj.art-c575f59cff094175aa2ae49476acfaf42023-11-20T11:13:34ZengMDPI AGAntibiotics2079-63822020-08-019953410.3390/antibiotics9090534Characterization of Fosfomycin and Nitrofurantoin Resistance Mechanisms in <i>Escherichia coli</i> Isolated in Clinical Urine SamplesAntonio Sorlozano-Puerto0Isaac Lopez-Machado1Maria Albertuz-Crespo2Luis Javier Martinez-Gonzalez3Jose Gutierrez-Fernandez4Department of Microbiology, School of Medicine and PhD Program in Clinical Medicine and Public Health, University of Granada-ibs, 18016 Granada, SpainDepartment of Microbiology, School of Medicine and PhD Program in Clinical Medicine and Public Health, University of Granada-ibs, 18016 Granada, SpainDepartment of Microbiology, School of Medicine and PhD Program in Clinical Medicine and Public Health, University of Granada-ibs, 18016 Granada, SpainPfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research (GENYO), 18016 Granada, SpainDepartment of Microbiology, School of Medicine and PhD Program in Clinical Medicine and Public Health, University of Granada-ibs, 18016 Granada, SpainFosfomycin and nitrofurantoin are antibiotics of choice to orally treat non-complicated urinary tract infections (UTIs) of community origin because they remain active against bacteria resistant to other antibiotics. However, epidemiologic surveillance studies have detected a reduced susceptibility to these drugs. The objective of this study was to determine possible mechanisms of resistance to these antibiotics in clinical isolates of fosfomycin- and/or nitrofurantoin-resistant UTI-producing <i>Escherichia coli</i>. We amplified and sequenced <i>murA</i>, <i>glpT</i>, <i>uhpT</i>, <i>uhpA</i>, <i>ptsI</i>, <i>cyaA</i>, <i>nfsA</i>, <i>nfsB</i>, and <i>ribE</i> genes, and screened plasmid-borne fosfomycin-resistance genes <i>fosA3</i>, <i>fosA4</i>, <i>fosA5</i>, <i>fosA6</i>, and <i>fosC2</i> and nitrofurantoin-resistance genes <i>oqxA</i> and <i>oqxB</i> by polymerase chain reaction. Among 29 isolates studied, 22 were resistant to fosfomycin due to deletion of <i>uhpT</i> and/or <i>uhpA</i> genes, and 2 also possessed the <i>fosA3</i> gene. Some modifications detected in sequences of NfsA (His11Tyr, Ser33Arg, Gln67Leu, Cys80Arg, Gly126Arg, Gly154Glu, Arg203Cys), NfsB (Gln44His, Phe84Ser, Arg107Cys, Gly192Ser, Arg207His), and RibE (Pro55His), and the production of truncated NfsA (Gln67 and Gln147) and NfsB (Glu54), were associated with nitrofurantoin resistance in 15/29 isolates; however, the presence of <i>oqxAB</i> plasmid genes was not detected in any isolate. Resistance to fosfomycin was associated with the absence of transporter UhpT expression and/or the presence of antibiotic-modifying enzymes encoded by <i>fosA3</i> plasmid-mediated gene. Resistance to nitrofurantoin was associated with modifications of NfsA, NfsB, and RibE proteins. The emergence and spread of these resistance mechanisms, including transferable resistance, could compromise the future usefulness of fosfomycin and nitrofurantoin against UTIs. Furthermore, knowledge of the genetic mechanisms underlying resistance may lead to rapid DNA-based testing for resistance.https://www.mdpi.com/2079-6382/9/9/534<i>Escherichia coli</i>fosfomycinnitrofurantoinantimicrobial resistance
spellingShingle Antonio Sorlozano-Puerto
Isaac Lopez-Machado
Maria Albertuz-Crespo
Luis Javier Martinez-Gonzalez
Jose Gutierrez-Fernandez
Characterization of Fosfomycin and Nitrofurantoin Resistance Mechanisms in <i>Escherichia coli</i> Isolated in Clinical Urine Samples
Antibiotics
<i>Escherichia coli</i>
fosfomycin
nitrofurantoin
antimicrobial resistance
title Characterization of Fosfomycin and Nitrofurantoin Resistance Mechanisms in <i>Escherichia coli</i> Isolated in Clinical Urine Samples
title_full Characterization of Fosfomycin and Nitrofurantoin Resistance Mechanisms in <i>Escherichia coli</i> Isolated in Clinical Urine Samples
title_fullStr Characterization of Fosfomycin and Nitrofurantoin Resistance Mechanisms in <i>Escherichia coli</i> Isolated in Clinical Urine Samples
title_full_unstemmed Characterization of Fosfomycin and Nitrofurantoin Resistance Mechanisms in <i>Escherichia coli</i> Isolated in Clinical Urine Samples
title_short Characterization of Fosfomycin and Nitrofurantoin Resistance Mechanisms in <i>Escherichia coli</i> Isolated in Clinical Urine Samples
title_sort characterization of fosfomycin and nitrofurantoin resistance mechanisms in i escherichia coli i isolated in clinical urine samples
topic <i>Escherichia coli</i>
fosfomycin
nitrofurantoin
antimicrobial resistance
url https://www.mdpi.com/2079-6382/9/9/534
work_keys_str_mv AT antoniosorlozanopuerto characterizationoffosfomycinandnitrofurantoinresistancemechanismsiniescherichiacoliiisolatedinclinicalurinesamples
AT isaaclopezmachado characterizationoffosfomycinandnitrofurantoinresistancemechanismsiniescherichiacoliiisolatedinclinicalurinesamples
AT mariaalbertuzcrespo characterizationoffosfomycinandnitrofurantoinresistancemechanismsiniescherichiacoliiisolatedinclinicalurinesamples
AT luisjaviermartinezgonzalez characterizationoffosfomycinandnitrofurantoinresistancemechanismsiniescherichiacoliiisolatedinclinicalurinesamples
AT josegutierrezfernandez characterizationoffosfomycinandnitrofurantoinresistancemechanismsiniescherichiacoliiisolatedinclinicalurinesamples